Atrium Therapeutics to Present Nonclinical Data Showing ATR 1072 Reversed and Improved Features of PRKAG2 Syndrome During HCMS at AHA Scientific Sessions 2026

The Quick Take
-- ATR 1072 impacted key characteristics of PRKAG2 syndrome, including accumulation of cardiac glycogen and cardiac hypertrophy -- -- Data further reinforce scientific rationale for ATR 1072 targeting the root cause of PRKAG2 syndrome -- -- Poster presentation November 6 at 5:30 p.m. CT...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Ebix Partners with intentyx to Bring AI Agent Security and Governance to Regulated Industries
Built on intentyx's SMARE platform, the offering helps insurers, financial institutions, healthcare organizations, and other regulated enterprises see what…
Business
Atlanta Built One of the Biggest Apartment Booms in Its History. Renters Who Can Pay Are Still Turned Away
With metro vacancy at 10.9%, the problem isn't supply. It's who gets approved. ATLANTA, Nov. 2, 2026 /PRNewswire/ -- Apartment vacancy across the Atlanta metro…
Business
What Does The Federal Government’s Registration Of 900+ Medical Cannabis Dispensaries Mean For Patients? (Op-Ed)
“For the first time, the federal government is recognizing and registering the medical cannabis dispensaries that patients fought to establish. This is a…
Business
Cracks in the A.I. Borrowing Binge
Investors are growing increasingly concerned about the debt-fueled spending spree at the heart of the artificial intelligence buildout.
